Psoriasis
3 stories
-
healthIxekizumab and Tirzepatide Combo Boosts Psoriasis and Weight Outcomes
Phase 3b trial shows ixekizumab plus tirzepatide significantly improves skin clearance and weight loss in psoriasis patients with obesity.
-
healthNew Protein Target PA2G4 Shows Promise for Psoriasis Treatment
Researchers identify Proliferation-Associated protein 2G4 (PA2G4) as a key driver of psoriasis, potentially offering a novel therapeutic target for the chronic skin condition.
-
healthKeratin Protein Discovery Offers New Hope for Skin Inflammation Treatments
New research reveals keratin's role in regulating skin inflammation, potentially leading to novel treatments for conditions like psoriasis and eczema.